Lexology January 24, 2025
On the heels of a nationwide push to regulate pharmacy benefit managers (PBMs), Massachusetts enacted a landmark piece of legislation to increase transparency and oversight within the pharmaceutical supply chain, specifically targeting PBMs. Signed into law by Governor Healey on January 9, 2025, the comprehensive bill, titled “An Act Relative to Pharmaceutical Access, Costs and Transparency” (the Act), introduces a multifaceted approach that aims to reduce prescription drug costs, enhance data transparency, and impose stronger oversight of PBMs and pharmaceutical manufacturers.
Key Provisions of the Act
Patient Cost Sharing Limitations: The Act mandates that certain health plans, including those offered by MassHealth, offer limited or no cost-sharing for specific generic and brand-name drugs for chronic illnesses, such as diabetes or...
Today's Sponsors
Today's Sponsor